New combination therapy exploits 'natural killer' cells to destroy head and neck tumors
Scientists have identified a new treatment combination that is highly effective at suppressing the growth of head and neck tumors.
Jun 16, 2022
0
5
Scientists have identified a new treatment combination that is highly effective at suppressing the growth of head and neck tumors.
Jun 16, 2022
0
5
Researchers from the University of Missouri School of Medicine have discovered a specific combination immunotherapy that shows promise in the fight against liver cancer.
May 18, 2022
0
7
A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered that exosomes derived from γδ-T cells (γδ-T-Exos) synergized with radiotherapy can control nasopharyngeal carcinoma (NPC) by ...
May 18, 2022
0
9
Researchers at Baylor College of Medicine and collaborating institutions have identified a combination therapy for treating triple-negative breast cancer (TNBC) that results in durable tumor regression in an animal model ...
Apr 27, 2022
0
27
Hundreds of thousands of people, mostly children living in Africa, succumb every year to malaria, an age-old mosquito-borne scourge that worsened during the COVID-19 pandemic.
Apr 23, 2022
1
34
Everyone wants to stay fit and healthy as they grow old. But as we age, our body degrades, our muscles shrink and strength declines. Some older people suffer from excessive muscle loss, a condition known as sarcopenia. University ...
Apr 20, 2022
0
98
Lifelong smoker Mike James had quit the habit for nearly three years when, through fluky circumstances, he found out that he had a small tumor in his right lung.
Apr 14, 2022
0
5
Researchers at Mayo Clinic's Center for Individualized Medicine have devised an immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively ...
Apr 13, 2022
0
94
Adding the immunotherapy drug nivolumab to chemotherapy before surgery (neoadjuvant) for patients with operable non-small cell lung cancer (NSCLC)—the leading cause of cancer deaths worldwide—reduced the risk of recurrence ...
Apr 11, 2022
0
3
Preliminary data from an artificial intelligence model could potentially predict side effects resulting from new combination therapies, according to results presented at the AACR Annual Meeting 2022, held April 8-13.
Apr 8, 2022
0
26